Haisco Pharmaceutical Group Co., Ltd.

SZSE:002653 Voorraadrapport

Marktkapitalisatie: CN¥40.5b

Haisco Pharmaceutical Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Haisco Pharmaceutical Group has a total shareholder equity of CN¥4.2B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 49.4%. Its total assets and total liabilities are CN¥6.9B and CN¥2.7B respectively. Haisco Pharmaceutical Group's EBIT is CN¥380.0M making its interest coverage ratio -3.5. It has cash and short-term investments of CN¥1.3B.

Belangrijke informatie

49.4%

Verhouding schuld/eigen vermogen

CN¥2.07b

Schuld

Rente dekkingsratio-3.5x
ContantCN¥1.29b
AandelenCN¥4.18b
Totaal verplichtingenCN¥2.73b
Totaal activaCN¥6.91b

Recente financiële gezondheidsupdates

Recent updates

Haisco Pharmaceutical Group's (SZSE:002653) Promising Earnings May Rest On Soft Foundations

Aug 22
Haisco Pharmaceutical Group's (SZSE:002653) Promising Earnings May Rest On Soft Foundations

With Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653) It Looks Like You'll Get What You Pay For

Jul 25
With Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653) It Looks Like You'll Get What You Pay For

Haisco Pharmaceutical Group (SZSE:002653) Has A Pretty Healthy Balance Sheet

Jul 04
Haisco Pharmaceutical Group (SZSE:002653) Has A Pretty Healthy Balance Sheet

Calculating The Fair Value Of Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653)

Jun 17
Calculating The Fair Value Of Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653)

These 4 Measures Indicate That Haisco Pharmaceutical Group (SZSE:002653) Is Using Debt Reasonably Well

Mar 19
These 4 Measures Indicate That Haisco Pharmaceutical Group (SZSE:002653) Is Using Debt Reasonably Well

Risks To Shareholder Returns Are Elevated At These Prices For Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653)

Feb 27
Risks To Shareholder Returns Are Elevated At These Prices For Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653)

Analyse van de financiële positie

Kortlopende schulden: 002653's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥1.4B).

Langlopende schulden: 002653's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥1.3B).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 002653's net debt to equity ratio (18.6%) is considered satisfactory.

Schuld verminderen: 002653's debt to equity ratio has increased from 47.3% to 49.4% over the past 5 years.

Schuldendekking: 002653's debt is well covered by operating cash flow (24.8%).

Rentedekking: 002653 earns more interest than it pays, so coverage of interest payments is not a concern.


Balans


Ontdek gezonde bedrijven